MX2020012348A - Composicion que comprende oligosacaridos de la leche humana para uso en la mejora, refuerzo, promocion o modulacion de una funcion gabaergica en el sistema nervioso central. - Google Patents
Composicion que comprende oligosacaridos de la leche humana para uso en la mejora, refuerzo, promocion o modulacion de una funcion gabaergica en el sistema nervioso central.Info
- Publication number
- MX2020012348A MX2020012348A MX2020012348A MX2020012348A MX2020012348A MX 2020012348 A MX2020012348 A MX 2020012348A MX 2020012348 A MX2020012348 A MX 2020012348A MX 2020012348 A MX2020012348 A MX 2020012348A MX 2020012348 A MX2020012348 A MX 2020012348A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- human milk
- modulating
- promoting
- enhancing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000003371 gabaergic effect Effects 0.000 title abstract 2
- 210000004251 human milk Anatomy 0.000 title abstract 2
- 235000020256 human milk Nutrition 0.000 title abstract 2
- 229920001542 oligosaccharide Polymers 0.000 title abstract 2
- 150000002482 oligosaccharides Chemical class 0.000 title abstract 2
- 210000003169 central nervous system Anatomy 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- IEQCXFNWPAHHQR-YKLSGRGUSA-N beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O IEQCXFNWPAHHQR-YKLSGRGUSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 235000013350 formula milk Nutrition 0.000 abstract 1
- IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Pediatric Medicine (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La invención se relaciona con una composición nutricional que comprende un oligosacárido de la leche humana (HMO) que tiene un efecto sobre en un mamífero para mejorar, reforzar, promover o modular una función GABAérgica en el SNC, preferentemente en un infante humano o un niños pequeños entre el nacimiento y los 7 años. La composición puede ser una fórmula infantil. El HMO puede ser 2FL, diFL y/o LNT y/o LNnT o combinaciones de estos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862689297P | 2018-06-25 | 2018-06-25 | |
PCT/EP2019/063035 WO2020001863A1 (en) | 2018-06-25 | 2019-05-21 | Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020012348A true MX2020012348A (es) | 2021-01-20 |
Family
ID=67105972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020012348A MX2020012348A (es) | 2018-06-25 | 2019-05-21 | Composicion que comprende oligosacaridos de la leche humana para uso en la mejora, refuerzo, promocion o modulacion de una funcion gabaergica en el sistema nervioso central. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20210268005A1 (es) |
EP (1) | EP3809879A1 (es) |
CN (1) | CN112218546B (es) |
AU (1) | AU2019296553B2 (es) |
BR (1) | BR112020023102A2 (es) |
CL (1) | CL2020002978A1 (es) |
MX (1) | MX2020012348A (es) |
PH (1) | PH12020551823A1 (es) |
WO (1) | WO2020001863A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4199932A1 (en) * | 2020-08-24 | 2023-06-28 | Intrinsic Medicine, Inc. | Immunomodulatory oligosaccharides for the treatment of autism spectrum disorder |
EP4313064A1 (en) * | 2021-03-22 | 2024-02-07 | Société des Produits Nestlé S.A. | Human milk oligosaccharides |
CN114223723A (zh) * | 2021-12-13 | 2022-03-25 | 黑龙江飞鹤乳业有限公司 | 营养组合物、包含其的食品以及该营养组合物的用途 |
WO2023237305A1 (en) * | 2022-06-09 | 2023-12-14 | Société des Produits Nestlé S.A. | Nutritional composition comprising gos and hmos |
WO2024175626A1 (en) * | 2023-02-22 | 2024-08-29 | Beneo-Orafti S.A. | Prebiotic composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0481038B1 (en) | 1990-04-16 | 2002-10-02 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
US5545553A (en) | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
US6045854A (en) | 1997-03-31 | 2000-04-04 | Abbott Laboraties | Nutritional formulations containing oligosaccharides |
DK2593466T3 (en) * | 2010-07-12 | 2018-07-16 | Univ California | Oligosaccharides from cow's milk |
BR112013016914A2 (pt) * | 2010-12-31 | 2019-09-24 | Abbott Lab | combinação simbiótica de probióticos e oligossacarídeos do leite humano para promover o crescimento de microbiota benéfica |
US10709770B2 (en) * | 2013-07-31 | 2020-07-14 | Mead Johnson Nutrition Company | Nutritional compositions containing a prebiotic and lactoferrin and uses thereof |
EP3079485B2 (en) * | 2013-12-13 | 2022-03-30 | Société des Produits Nestlé S.A. | Use of a modified sweet whey and a modified sweet whey containing infant formula for promoting the postnatal development of the infant central nervous system and related cognitive functions |
EP3212012A1 (en) * | 2014-10-31 | 2017-09-06 | Nestec S.A. | Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition |
WO2016145628A1 (en) * | 2015-03-18 | 2016-09-22 | Nestec S.A. | Composition comprising siallyllactose for use in enhancing learning skills and memory function |
US20180103675A1 (en) * | 2016-10-14 | 2018-04-19 | Mead Johnson Nutrition Company | Personalized pediatric nutrition products comprising human milk oligosaccharides |
-
2019
- 2019-05-21 EP EP19733949.2A patent/EP3809879A1/en active Pending
- 2019-05-21 MX MX2020012348A patent/MX2020012348A/es unknown
- 2019-05-21 BR BR112020023102-9A patent/BR112020023102A2/pt unknown
- 2019-05-21 WO PCT/EP2019/063035 patent/WO2020001863A1/en unknown
- 2019-05-21 AU AU2019296553A patent/AU2019296553B2/en active Active
- 2019-05-21 CN CN201980037220.2A patent/CN112218546B/zh active Active
- 2019-05-21 US US17/255,013 patent/US20210268005A1/en active Pending
-
2020
- 2020-10-29 PH PH12020551823A patent/PH12020551823A1/en unknown
- 2020-11-17 CL CL2020002978A patent/CL2020002978A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20210268005A1 (en) | 2021-09-02 |
WO2020001863A1 (en) | 2020-01-02 |
CN112218546B (zh) | 2024-05-24 |
AU2019296553B2 (en) | 2024-10-10 |
PH12020551823A1 (en) | 2021-05-17 |
BR112020023102A2 (pt) | 2021-02-02 |
AU2019296553A1 (en) | 2020-11-19 |
CL2020002978A1 (es) | 2021-05-07 |
EP3809879A1 (en) | 2021-04-28 |
CN112218546A (zh) | 2021-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020551823A1 (en) | Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system | |
PH12020551822A1 (en) | Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system | |
PH12021551077A1 (en) | A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier | |
PH12019550168A1 (en) | Composition comprising human milk oligosaccharides (hmo) for use in the improvement of short term memory and other cognitive benefits | |
PH12018501325A1 (en) | Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion | |
PH12018501221A1 (en) | Mixture of hmos | |
MX2022013835A (es) | Produccion sinergica de butirato asociada con la complejidad de la mezcla de hmo para usar en infantes o niños pequeños en con fines de salud. | |
PH12018501328A1 (en) | Compositions comprising 2fl and lnnt for use in infants or young children to prevent later in life obesity or related comorbidities | |
PH12017502350A1 (en) | Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants | |
PH12020550959A1 (en) | Compositions for use in the reduction of nociception in infants and young children | |
PH12017550044A1 (en) | Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children | |
PH12017550040A1 (en) | Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children | |
PH12021551071A1 (en) | A nutritional composition comprising 6`sl and lnt in combination to improve the gastrointestinal barrier function | |
PH12017550041A1 (en) | Compositions for use in improving stool consistency or frequency in infants or young children | |
PH12018501262A1 (en) | Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies | |
PH12018501324A1 (en) | COMPOSITIONS COMPRISING 2FL AND LNnT TO CONTROL FOOD INTAKE AND GROWTH IN INFANTS OR YOUNG CHILDREN | |
PH12018501298A1 (en) | Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound | |
MX2019011334A (es) | Composicion que comprende oligofructosa (of) para usar en la mejora de la memoria a corto plazo y otros beneficios congnitivos. | |
PH12018501297A1 (en) | Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders | |
PH12015502543A1 (en) | Anti-regurgitation composition maintaining gut motility | |
ZA202004246B (en) | Compositions comprising at least on n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children | |
PH12019500092A1 (en) | Nutritional compositions for infants and/or young children comprising oligosaccharides | |
MX2022006411A (es) | Composiciones que comprenden oligosacaridos de la leche humana para uso en un sujeto para apoyar el desarrollo del lenguaje. | |
EP4321211A3 (en) | Nutritional composition comprising urea and non-digestible oligosaccharides | |
UA104395C2 (en) | Whipped sweets "miakyi nuhatyn" (soft nougatine) |